Glaucoma Research Foundation (GRF) announced today $720,000 in annual research grants to support 12 investigators at prestigious universities across the United States.
A new study from University of Michigan Kellogg Eye Center links familial relationships to the likelihood older adults will get needed cataract surgery — a procedure with broad implications for health.
People whose eyes show signs of small changes in blood vessels at age 60 may be more likely to develop thinking and memory problems by the time they are 80 than people with healthy eyes, according to a study published in the February 28, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. Boston, Mass. — Scientists and advocates today announced the formation of Odylia Therapeutics, a nonprofit corporation dedicated to creating gene therapies for ultra-rare genetic conditions causing blindness.
A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration (AMD). By using the latest technologies to visualize structures within the eye and measure their function, researchers hope to identify biomarkers of disease progression, well before it advances to late-stage disease and causes vision loss.
The Shaffer Prize, presented annually by Glaucoma Research Foundation, recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand glaucoma.
Through a partnership with John Hancock Financial Services, Massachusetts Eye and Ear is preparing a team of runners for the 2018 Boston Marathon.® “Team Eye and Ear” comprises 67 members fundraising in support of Mass. Eye and Ear’s research programs to fight disorders of the eyes, ears, nose, throat, head and neck.
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, have developed a new computational tool to screen patients with common but blinding retinal diseases, potentially speeding diagnoses and treatment.
UCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses. The study is the first prospective, longitudinal approach to examine supportive care needs among patients with this disease, and suggested more acute needs among people with uveal melanoma than people with other cancers.
Tim Goetz drives about 200,000 miles each year. Remarkably, Goetz is legally blind. Research funded by the National Eye Institute (NEI) is helping Goetz and others like him get or stay behind the wheel while keeping roads safe for everyone.
Diabetic eye disease is the leading cause of blindness among people ages 40 to 60. The longer you have diabetes, the greater your likelihood of developing vision problems increases.
David A. Solá-Del Valle, M.D., a board-certified ophthalmologist and fellowship-trained glaucoma specialist, has recently joined the Glaucoma Service at Mass. Eye and Ear.
Janey L. Wiggs, M.D., Ph.D., FARVO, Associate Chief of Ophthalmology Clinical Research and Associate Director of the Howe Laboratory at Massachusetts Eye and Ear, is the 2018 recipient of the Dr. David L. Epstein Award
A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer’s and Parkinson’s, according to findings released today in the Proceedings of the National Academy of Sciences (PNAS).
Jakub Famulski, an assistant professor of biology at the University of Kentucky, has received an R01 grant for over $1.8 million from the National Institutes of Health to study the early formation of the anterior segment of the eye, which includes the cornea, iris, ciliary muscle, drainage canals and pupil.
People with a mutated ATF6 gene have a malformed or missing fovea, severely limiting vision. UC San Diego School of Medicine researchers first linked ATF6 to this type of vision impairment. Now the team discovered that a chemical that activates ATF6 converts patient stem cells into blood vessels.
The recent approval of two novel medications for glaucoma – the first new medications for the disorder in nearly 18 years – are fruit borne from decades of foundational scientific research supported by the National Eye Institute (NEI). The two medications, Vyzulta and Rhopressa, treat elevated eye pressure. High intraocular pressure is a causal risk factor for primary open-angle glaucoma, the most common form of glaucoma and a leading cause of vision loss and blindness in the U.S. and worldwide.
The Catalyst Award, Glaucoma Research Foundation's highest honor, will be presented to Thomas W. Burns, President and CEO of Glaukos Corporation (Laguna Hills, CA), in recognition of his remarkable leadership and commitment to the development of innovative glaucoma treatments.
Glaucoma Research Foundation will host the 7th Annual Glaucoma 360 from February 8th to February 10th in San Francisco. This signature three-day event highlights innovation in glaucoma to ensure patients have access to the latest and most effective treatment options.
Contrary to long-established dogma, the eye can host an active immune response that could both heal injury and contribute to loss of vision.
Gender-based differences may influence several ocular conditions, suggesting that fluctuations in sex steroid homeostasis may have direct effects on eye physiology and the pathogenesis of conditions like Age-Related Macular Degeneration (AMD).
In a study published today in the scientific journal Investigative Ophthalmology and Visual Science, Kaufman and Curtis Brandt, a fellow professor of ophthalmology and visual sciences at UW-Madison, showed an improved tactic for delivering new genes into the eye's fluid drain, called the trabecular meshwork. It could lead to a treatment for glaucoma.
Duke Health researchers found baseball players with higher scores on vision and motor tasks completed on large touch-screen machines called Nike Sensory Stations had better on-base percentages, more walks and fewer strikeouts -- collectively referred to as plate discipline -- compared to their peers.
Drivers’ limited capacity to process the myriad details they absorb could explain why they sometimes fail to avoid crashes with motorcycles.
Common, unavoidable eye movements may be a cause of glaucoma in people with normal intraocular pressure (normal-tension glaucoma), according to new research supported by the National Eye Institute. The findings suggest that over time eye movement strains the optic nerve, the bundle of nerve fibers between the eye and brain. The research may also explain why tension-lowering eye drops can improve normal-tension glaucoma. Glaucoma is the second leading cause of blindness worldwide and January is Glaucoma Awareness Month.
In his bestsellers The Tipping Point, Blink and Outliers, Malcolm Gladwell writes about the unexpected implications of scientific research, urging readers to think different. In an editorial published this month in Ophthalmology, the journal of the American Academy of Ophthalmology, Gladwell offers another example of his stock in trade: To make medical students better doctors, send them to art school.
If you struggle with nearsightedness, farsightedness, and/or astigmatism, you probably wear glasses or contact lenses to help you to see. This can be frustrating, especially if you misplace your glasses or lose a contact lens. You’ve probably heard of LASIK eye surgery and may be wondering if the procedure is right for you.
Scientists at the National Eye Institute (NEI), part of the National Institutes of Health, report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE)—a layer of cells in the back of the eye—are essential for the survival of the retina’s light-sensing photoreceptors. The discovery has advanced efforts to make stem cell-derived RPE for transplantation into patients with geographic atrophy, otherwise known as dry age-related macular degeneration (AMD), a leading cause of blindness in the U.S. The study appears in the January 2 Cell Reports.
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels in the retina, leading to blindness. In experiments that suppressed vascular endothelial growth factor (VEGF) in the eye, researchers were able to re-establish normal blood flow in the retina, offering a potential means of stalling or even reversing diabetes-related blindness.
UCLA researchers, after developing a mouse model of Friedreich’s ataxia that shows symptoms similar to patients, have found that many early symptoms of the disease are completely reversible when the genetic defect linked to the ataxia is reversed
Knowing that individuals with insomnia are also unlikely to change their ways, researchers from Columbia University Medical Center tested a method to reduce the adverse effects of evening ambient light exposure, while still allowing use of blue light-emitting devices. Their findings will be published in the January issue of Journal of Psychiatric Research.
In a phase 1/2a study jCyte's investigational therapy, jCell, showed a good safety profile and indications of potential benefit for patients with retinitis pigmentosa
Dr. Jeff Goldberg: I really want to thank the Glaucoma Research Foundation. Obviously, what we’re going to talk about today would not come to fruition without the support of the Glaucoma Research Foundation and of course, all of their supporters.
A new study quantifying a 21-fold return on investment suggests an efficient — and non-partisan — method to cut healthcare spending is to invest in basic research. The paper tracks how a new technology aids doctors in reducing the number of unnecessary drug injections used to treat a blinding condition called wet age-related macular degeneration (AMD)
Research Could Lead to New Treatment for Solar Retinopathy
It is easy to remember steps to prevent the body from getting cold, but what can be done to protect the eyes when cold weather hits?
A team of scientists and engineers at USC has developed an on-the-spot, temperature-sensitive gel that could seal eye injuries on the battlefield.
Faculty at NYU School of Medicine report that a healthcare center in India's model for cataract surgery emits 96 percent less carbon than in the United Kingdom -- and a likely even greater savings in the United States -- while yielding comparable or better health outcomes for one of the world’s most common surgical procedures.
Anyone with normal vision knows that a ball that seems to quickly be growing larger is probably going to hit them on the nose. But strap them into a virtual reality headset, and they still may need to take a few lumps before they pay attention to the visual cues that work so well in the real world, according to a new study from University of Wisconsin–Madison psychologists.
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
Novice military pilots can improve their visual responses to a simulated emergency procedure by observing the eye movements of expert pilots, according to new research from SUNY Downstate Medical Center.
A University of Michigan Kellogg Eye Center study shows over the past decade the proportion of cataract surgeries performed at surgery centers has outpaced surgeries done in hospitals.
The popularity of the Nerf “blaster” toy gun has created an active market for inexpensive off-brand versions of the Nerf darts, but new data from Virginia Tech suggests that the off-brand darts are two to three times more likely to cause eye injuries.
Fortified and biofortified foods are at the forefront of efforts to combat vitamin A deficiency worldwide. But little is known about what influence processing may have on the retention of vitamin A precursors in these foods. Now in a study appearing in ACS Omega, scientists report that a high percentage of these healthful substances — in some cases, almost all — can survive cooking, depending on the preparation method.
Brahim Chaqour, PhD, professor of cell biology and ophthalmology at SUNY Downstate Medical Center, has received two awards to support research into treatment of currently incurable vision-threatening diseases. The new awards, totaling $2,008,973, are from the National Eye Institute of the National Institutes of Health (NIH).
A new kind of eyedropper can deliver tiny droplets of medication, treating the eye more precisely than traditional eyedroppers, while reducing waste and avoiding dangerous side effects.
People who engage in moderate to vigorous physical activity may be able to significantly lower their risk of glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
A review of patients who suffered firearms-related eye trauma shows significant disparities in race, location, and circumstance, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right